Sign In
Free Newsletter
FDA commissioner Makary is resigning, sources say
FDA commissioner Marty Makary plans to resign amid pressure from Republicans and White House clashes, marking a leadership change at the federal health agency.
US reclassifies certain marijuana products as a less-dangerous drug
The U.S. Department of Justice reschedules FDA-approved marijuana from Schedule I to Schedule III, easing research and industry restrictions.
FDA’s new expert panels are rife with financial conflicts and fringe views
FDA Commissioner Marty Makary is using informal expert panels on antidepressants, menopause drugs and talc, raising conflict-of-interest concerns.
Juul settles with Va., 32 other states for $438.5M
After a two-year investigation, ongoing federal scrutiny and numerous lawsuits, Juul Labs Inc. tentatively settled with Virginia, 32 other states and Puerto Rico for $438.5 million on Tuesday. Virginia will receive $16.61 million over the next six to 10 years, state Attorney General Jason Miyares announced Tuesday, but the larger impact may be on Henrico […]
REI Systems secures $400M FDA contract
Sterling-based IT company REI Systems secured a five-year, $400 million contract from the U.S. Food and Drug Administration, the company announced Tuesday. Under the single-award Criminal Investigations, Imports and Systems Inspection Regulatory Compliance and Enforcement contract, REI will support the FDA‘s Office of Regulatory Affairs in the development and operations of mission-critical s[...]
